Andrew Quon

Title(s)HS Clinical Professor, Molecular and Medical Pharmacology
SchoolMedicine
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    FLT-PET/CT for Therapy Monitoring of DLBCL
    NIH R01CA152923Jun 1, 2011 - Aug 31, 2018
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non-Small Cell Lung Cancer. J Clin Oncol. 2024 Nov 20; 42(33):3935-3946. Kong FS, Hu C, Pryma DA, Duan F, Matuszak M, Xiao Y, Ten Haken R, Siegel MJ, Hanna L, Curran WJ, Dunphy M, Gelblum D, Piert M, Jolly S, Robinson CG, Quon A, Loo BW, Srinivas S, Videtic GM, Faria SL, Ferguson C, Dunlap NE, Kundapur V, Paulus R, Siegel BA, Bradley JD, Machtay M. PMID: 39365957.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    2. FAPI PET uptake patterns after invasive medical interventions: a single center retrospective analysis. Eur J Nucl Med Mol Imaging. 2024 Sep; 51(11):3373-3385. Maliha PG, Hotta M, Farolfi A, Grogan T, Alano R, Limon A, Lam E, Carlucci G, Bahri S, Salavati A, Benz M, Silverman D, Gupta P, Quon A, Allen-Auerbach M, Czernin J, Calais J. PMID: 38750372.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Detection of Recurrence After Thoracic Stereotactic Ablative Radiotherapy Using FDG-PET-CT. Clin Lung Cancer. 2022 05; 23(3):282-289. Sodji QH, Harris JP, Quon A, Modlin LA, Lau B, Jiang A, Trakul N, Maxim PG, Diehn M, Loo BW, Hiniker SM. PMID: 35246393.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. 18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma. J Nucl Med. 2022 Feb; 63(2):199-204. Benz MR, Armstrong WR, Ceci F, Polverari G, Donahue TR, Wainberg ZA, Quon A, Auerbach M, Girgis MD, Herrmann K, Czernin J, Calais J. PMID: 34272317.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    5. Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312). J Nucl Med. 2021 Oct; 62(10):1447-1456. Calais J, Czernin J, Thin P, Gartmann J, Nguyen K, Armstrong WR, Allen-Auerbach M, Quon A, Bahri S, Gupta P, Gardner L, Dahlbom M, He B, Esfandiari R, Ranganathan D, Herrmann K, Eiber M, Fendler WP, Delpassand E. PMID: 34272322; PMCID: PMC8724902.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    6. Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort. J Nucl Med. 2021 Oct; 62(10):1440-1446. Calais J, Gafita A, Eiber M, Armstrong WR, Gartmann J, Thin P, Nguyen K, Lok V, Gosa L, Grogan T, Esfandiari R, Allen-Auerbach M, Quon A, Bahri S, Gupta P, Gardner L, Ranganathan D, Slavik R, Dahlbom M, Herrmann K, Delpassand E, Fendler WP, Czernin J. PMID: 34016732; PMCID: PMC8724893.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    7. 18F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study. Eur J Nucl Med Mol Imaging. 2021 08; 48(9):2883-2893. Minamimoto R, Fayad L, Vose J, Meza J, Advani R, Hankins J, Mottaghy F, Macapinlac H, Heinzel A, Juweid ME, Quon A. PMID: 33909086; PMCID: PMC8263539.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    8. A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408. Clin Cancer Res. 2020 09 01; 26(17):4468-4477. Evens AM, Hong F, Habermann TM, Advani RH, Gascoyne RD, Witzig TE, Quon A, Ranheim EA, Ansell SM, Cheema PS, Dy PA, O'Brien TE, Winter JN, Cescon TP, Chang JE, Kahl BS. PMID: 32532790; PMCID: PMC7722783.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    9. 18F-FAC PET Visualizes Brain-Infiltrating Leukocytes in a Mouse Model of Multiple Sclerosis. J Nucl Med. 2020 05; 61(5):757-763. Chen BY, Ghezzi C, Villegas B, Quon A, Radu CG, Witte ON, Clark PM. PMID: 31653711; PMCID: PMC7198381.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    10. Can the Injected Dose Be Reduced in 68Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection? J Nucl Med. 2020 02; 61(2):189-193. Rauscher I, Fendler WP, Hope TA, Quon A, Nekolla SG, Calais J, Richter A, Haller B, Herrmann K, Weber WA, Czernin J, Eiber M. PMID: 31324710; PMCID: PMC8801954.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    11. Association of Tumor [18F]FDG Activity and Diffusion Restriction with Clinical Outcomes of Rhabdomyosarcomas. Mol Imaging Biol. 2019 06; 21(3):591-598. Pourmehdi Lahiji A, Jackson T, Nejadnik H, von Eyben R, Rubin D, Spunt SL, Quon A, Daldrup-Link H. PMID: 30187233; PMCID: PMC6401335.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    12. FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study. Front Oncol. 2019; 9:467. Hiniker SM, Sodji Q, Quon A, Gutkin PM, Arksey N, Graves EE, Chin FT, Maxim PG, Diehn M, Loo BW. PMID: 31214507; PMCID: PMC6555304.
      View in: PubMed   Mentions: 6  
    13. GFPT2-Expressing Cancer-Associated Fibroblasts Mediate Metabolic Reprogramming in Human Lung Adenocarcinoma. Cancer Res. 2018 07 01; 78(13):3445-3457. Zhang W, Bouchard G, Yu A, Shafiq M, Jamali M, Shrager JB, Ayers K, Bakr S, Gentles AJ, Diehn M, Quon A, West RB, Nair V, van de Rijn M, Napel S, Plevritis SK. PMID: 29760045; PMCID: PMC6030462.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    14. How to Provide Gadolinium-Free PET/MR Cancer Staging of Children and Young Adults in Less than 1 h: the Stanford Approach. Mol Imaging Biol. 2018 04; 20(2):324-335. Muehe AM, Theruvath AJ, Lai L, Aghighi M, Quon A, Holdsworth SJ, Wang J, Luna-Fineman S, Marina N, Advani R, Rosenberg J, Daldrup-Link HE. PMID: 28721605; PMCID: PMC5773418.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    15. Impact of 68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence. J Nucl Med. 2018 03; 59(3):434-441. Calais J, Fendler WP, Eiber M, Gartmann J, Chu FI, Nickols NG, Reiter RE, Rettig MB, Marks LS, Ahlering TE, Huynh LM, Slavik R, Gupta P, Quon A, Allen-Auerbach MS, Czernin J, Herrmann K. PMID: 29242398; PMCID: PMC5868499.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    16. Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer. Radiother Oncol. 2017 11; 125(2):338-343. Gensheimer MF, Hong JC, Chang-Halpenny C, Zhu H, Eclov NCW, To J, Murphy JD, Wakelee HA, Neal JW, Le QT, Hara WY, Quon A, Maxim PG, Graves EE, Olson MR, Diehn M, Loo BW. PMID: 28830717.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    17. Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis. Clin Nucl Med. 2017 Jul; 42(7):e328-e334. Hanneman K, Kadoch M, Guo HH, Jamali M, Quon A, Iagaru A, Herfkens R. PMID: 28418949.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    18. Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative 18F FDG-PET/CT metrics. Oncotarget. 2017 Aug 08; 8(32):52792-52801. Minamimoto R, Jamali M, Gevaert O, Echegaray S, Khuong A, Hoang CD, Shrager JB, Plevritis SK, Rubin DL, Leung AN, Napel S, Quon A. PMID: 28881771; PMCID: PMC5581070.
      View in: PubMed   Mentions: 18     Fields:    
    19. Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are Implemented. J Nucl Med. 2017 11; 58(11):1793-1796. Calais J, Czernin J, Eiber M, Fendler WP, Gartmann J, Heaney AP, Hendifar AE, Pisegna JR, Hecht JR, Wolin EM, Slavik R, Gupta P, Quon A, Schiepers C, Allen-Auerbach MS, Herrmann K. PMID: 28473600; PMCID: PMC5666645.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    20. VISUAL VIGNETTE. Endocr Pract. 2017 Oct; 23(10):1276. Yu R, Quon A, Hecht JR. PMID: 28332878.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. PET/MRI of metabolic activity in osteoarthritis: A feasibility study. J Magn Reson Imaging. 2017 06; 45(6):1736-1745. Kogan F, Fan AP, McWalter EJ, Oei EHG, Quon A, Gold GE. PMID: 27796082; PMCID: PMC5761655.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    22. Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PET. Pract Radiat Oncol. 2017 Mar - Apr; 7(2):120-125. Toesca DAS, Pollom EL, Poullos PD, Flynt L, Cui Y, Quon A, von Eyben R, Koong AC, Chang DT. PMID: 28274396.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. Spectrum of 68Ga-DOTA TATE Uptake in Patients With Neuroendocrine Tumors. Clin Nucl Med. 2016 Jun; 41(6):e281-7. Moradi F, Jamali M, Barkhodari A, Schneider B, Chin F, Quon A, Mittra ES, Iagaru A. PMID: 26673240.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    24. Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell Carcinoma. PLoS One. 2016; 11(4):e0153321. Minamimoto R, Barkhodari A, Harshman L, Srinivas S, Quon A. PMID: 27123976; PMCID: PMC4849767.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    25. Speeding up PET/MR for cancer staging of children and young adults. Eur Radiol. 2016 Dec; 26(12):4239-4248. Aghighi M, Pisani LJ, Sun Z, Klenk C, Madnawat H, Fineman SL, Advani R, Von Eyben R, Owen D, Quon A, Moseley M, Daldrup-Link HE. PMID: 27048532; PMCID: PMC5052123.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    26. Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring. Radiology. 2016 07; 280(1):220-9. Minamimoto R, Fayad L, Advani R, Vose J, Macapinlac H, Meza J, Hankins J, Mottaghy F, Juweid M, Quon A. PMID: 26854705; PMCID: PMC4934532.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    27. Correlation between arterial spin labeling MRI and dynamic FDG on PET-MR in Alzheimer's disease and non-Alzhiemer's disease patients. EJNMMI Phys. 2015 Dec; 2(Suppl 1):A83. Douglas D, Goubran M, Wilson E, Xu G, Tripathi P, Holley D, Chao S, Wintermark M, Quon A, Zeineh M, Vasanawala M, Zaharchuk G. PMID: 26956345; PMCID: PMC4798659.
      View in: PubMed   Mentions:
    28. Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era. Int J Radiat Oncol Biol Phys. 2015 May 01; 92(1):99-106. Hiniker SM, Pollom EL, Khodadoust MS, Kozak MM, Xu G, Quon A, Advani RH, Hoppe RT. PMID: 25863757.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    29. 18F-sodium fluoride PET/CT in oncology: an atlas of SUVs. Clin Nucl Med. 2015 Apr; 40(4):e228-31. Sabbah N, Jackson T, Mosci C, Jamali M, Minamimoto R, Quon A, Mittra ES, Iagaru A. PMID: 25546225.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    30. Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404). Br J Haematol. 2015 Jul; 170(1):56-65. Swinnen LJ, Li H, Quon A, Gascoyne R, Hong F, Ranheim EA, Habermann TM, Kahl BS, Horning SJ, Advani RH. PMID: 25823885; PMCID: PMC4696544.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    31. Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic Factors. Clin Lung Cancer. 2015 Nov; 16(6):475-85. Harris JP, Chang-Halpenny CN, Maxim PG, Quon A, Graves EE, Diehn M, Loo BW. PMID: 25770888.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    32. Value of 18F-FDG PET and PET/CT for evaluation of pediatric malignancies. J Nucl Med. 2015 Feb; 56(2):274-86. Uslu L, Donig J, Link M, Rosenberg J, Quon A, Daldrup-Link HE. PMID: 25572088.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    33. Simultaneous whole-body time-of-flight 18F-FDG PET/MRI: a pilot study comparing SUVmax with PET/CT and assessment of MR image quality. Clin Nucl Med. 2015 Jan; 40(1):1-8. Iagaru A, Mittra E, Minamimoto R, Jamali M, Levin C, Quon A, Gold G, Herfkens R, Vasanawala S, Gambhir SS, Zaharchuk G. PMID: 25489952; PMCID: PMC6319383.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    34. (18)F-FDG PET/CT scans for children and adolescents - authors' reply. Lancet Oncol. 2014 Jun; 15(7):e244. Daldrup-Link H, Quon A, Goske M. PMID: 24872100.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Classic biphasic pulmonary blastoma demonstrated by 18F-FDG PET/CT. Clin Nucl Med. 2014 Apr; 39(4):346-8. Keu KV, Berry GJ, Quon A. PMID: 23989445.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    36. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder. Nucl Med Commun. 2014 Mar; 35(3):276-81. Takehana CS, Twist CJ, Mosci C, Quon A, Mittra E, Iagaru A. PMID: 24296883.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    37. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study. Lancet Oncol. 2014 Mar; 15(3):275-85. Klenk C, Gawande R, Uslu L, Khurana A, Qiu D, Quon A, Donig J, Rosenberg J, Luna-Fineman S, Moseley M, Daldrup-Link HE. PMID: 24559803.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    38. Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal. J Nucl Med. 2013 Jan; 54(1):27-32. Bazan JG, Koong AC, Kapp DS, Quon A, Graves EE, Loo BW, Chang DT. PMID: 23236018.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    39. Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence. Cancer. 2013 Apr 01; 119(7):1349-56. Ho AS, Tsao GJ, Chen FW, Shen T, Kaplan MJ, Colevas AD, Fischbein NJ, Quon A, Le QT, Pinto HA, Fee WE, Sunwoo JB, Sirjani D, Hara W, Yao M. PMID: 23225544.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    40. Dipeptidyl peptidase 4 inhibition increases myocardial glucose uptake in nonischemic cardiomyopathy. J Card Fail. 2012 Oct; 18(10):804-9. Witteles RM, Keu KV, Quon A, Tavana H, Fowler MB. PMID: 23040117.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    41. Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy. Lung Cancer. 2012 Dec; 78(3):219-24. Abelson JA, Murphy JD, Trakul N, Bazan JG, Maxim PG, Graves EE, Quon A, Le QT, Diehn M, Loo BW. PMID: 23009727.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    42. FDG-PET/CT Initial and Subsequent Therapy Evaluation: Progressing to PET/MR Imaging. PET Clin. 2012 Oct; 7(4):369-80. Mosci C, Davidzon GA, Quon A. PMID: 27157644.
      View in: PubMed   Mentions: 3     Fields:    
    43. Initial investigation of ¹⁸F-NaF PET/CT for identification of vertebral sites amenable to surgical revision after spinal fusion surgery. Eur J Nucl Med Mol Imaging. 2012 Nov; 39(11):1737-44. Quon A, Dodd R, Iagaru A, de Abreu MR, Hennemann S, Alves Neto JM, Sprinz C. PMID: 22895860; PMCID: PMC3464378.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    44. Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Am J Clin Oncol. 2012 Aug; 35(4):334-9. Chennupati SK, Quon A, Kamaya A, Pai RK, La T, Krakow TE, Graves E, Koong AC, Chang DT. PMID: 21422989.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    45. Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results. Radiology. 2012 Aug; 264(2):387-96. Gevaert O, Xu J, Hoang CD, Leung AN, Xu Y, Quon A, Rubin DL, Napel S, Plevritis SK. PMID: 22723499; PMCID: PMC3401348.
      View in: PubMed   Mentions: 201     Fields:    Translation:Humans
    46. Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer. Cancer Res. 2012 Aug 01; 72(15):3725-34. Nair VS, Gevaert O, Davidzon G, Napel S, Graves EE, Hoang CD, Shrager JB, Quon A, Rubin DL, Plevritis SK. PMID: 22710433; PMCID: PMC3596510.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    47. Comparison of MRI and ¹⁸F-NaF PET/CT in patients with patellofemoral pain. J Magn Reson Imaging. 2012 Oct; 36(4):928-32. Draper CE, Quon A, Fredericson M, Besier TF, Delp SL, Beaupre GS, Gold GE. PMID: 22549985; PMCID: PMC3411864.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    48. Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer. Int J Radiat Oncol Biol Phys. 2012 Oct 01; 84(2):471-7. Jayachandran P, Pai RK, Quon A, Graves E, Krakow TE, La T, Loo BW, Koong AC, Chang DT. PMID: 22381904.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    49. Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's disease. Radiat Oncol. 2012 Jan 19; 7:5. Tseng D, Rachakonda LP, Su Z, Advani R, Horning S, Hoppe RT, Quon A, Graves EE, Loo BW, Tran PT. PMID: 22260710; PMCID: PMC3398283.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    50. Pattern of 18F-FDG uptake in the spinal cord in patients with non-central nervous system malignancy. Spine (Phila Pa 1976). 2011 Oct 01; 36(21):E1395-401. Do BH, Mari C, Tseng JR, Quon A, Rosenberg J, Biswal S. PMID: 21311407.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    51. Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer. Clin Lung Cancer. 2012 Jan; 13(1):52-58. Lee P, Bazan JG, Lavori PW, Weerasuriya DK, Quon A, Le QT, Wakelee HA, Graves EE, Loo BW. PMID: 21703935; PMCID: PMC4296977.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    52. Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer. J Thorac Oncol. 2011 May; 6(5):920-6. Kozak MM, Murphy JD, Schipper ML, Donington JS, Zhou L, Whyte RI, Shrager JB, Hoang CD, Bazan J, Maxim PG, Graves EE, Diehn M, Hara WY, Quon A, Le QT, Wakelee HA, Loo BW. PMID: 21774104.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    53. 18F-5-fluorouracil dynamic positron emission tomography/computed tomography shows decreased tracer activity after bevacizumab in colorectal metastases. Nucl Med Commun. 2011 May; 32(5):343-7. Zissen MH, Kunz P, Subbarayan M, Chin FT, Conti PS, Fisher GA, Quon A. PMID: 21412178.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    54. Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2011 Jun 01; 80(2):514-21. Murphy JD, La TH, Chu K, Quon A, Fischbein NJ, Maxim PG, Graves EE, Loo BW, Le QT. PMID: 20646870; PMCID: PMC2962876.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    55. Efficacy of 18F-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma. Eur J Nucl Med Mol Imaging. 2009 Dec; 36(12):1952-9. Mittra E, El-Maghraby T, Rodriguez CA, Quon A, McDougall IR, Gambhir SS, Iagaru A. PMID: 19585114; PMCID: PMC4157596.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    56. Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study. Blood. 2010 Jan 28; 115(4):775-7; quiz 918. Horning SJ, Juweid ME, Schöder H, Wiseman G, McMillan A, Swinnen LJ, Advani R, Gascoyne R, Quon A. PMID: 19767508; PMCID: PMC2815514.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCTClinical Trials
    57. Focal fat mimicking multiple hepatic metastases on FDG PET/CT imaging. Eur J Nucl Med Mol Imaging. 2009 Sep; 36(9):1527. Zissen MH, Quon A. PMID: 19562337.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    58. Simulations of virtual PET/CT 3-D bronchoscopy imaging using a physical porcine lung-heart phantom. Mol Imaging Biol. 2009 Jul-Aug; 11(4):275-82. Yerushalmi D, Mullick R, Quon A, Fahrig R, Pelc NJ, Fann JI, Gambhir SS. PMID: 19434462.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    59. Detection of solitary humeral metastasis from pancreatic adenocarcinoma with F-18 FDG PET/CT. Clin Nucl Med. 2009 May; 34(5):312-3. Kim J, Quon A, Humke E, Ford JM, Koong AC. PMID: 19387214.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    60. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study. J Nucl Med. 2009 Apr; 50(4):501-5. Iagaru A, Mittra E, Yaghoubi SS, Dick DW, Quon A, Goris ML, Gambhir SS. PMID: 19289439.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimals
    61. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer. 2009 Feb 01; 115(3):665-72. Chang DT, Schellenberg D, Shen J, Kim J, Goodman KA, Fisher GA, Ford JM, Desser T, Quon A, Koong AC. PMID: 19117351.
      View in: PubMed   Mentions: 149     Fields:    Translation:Humans
    62. Positron emission tomography/computed tomography: the current technology and applications. Radiol Clin North Am. 2009 Jan; 47(1):147-60. Mittra E, Quon A. PMID: 19195540.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    63. PET/CT imaging of gastrointestinal stromal tumor with calcified peritoneal implants after imatinib therapy. Clin Nucl Med. 2008 Dec; 33(12):864-5. Eslamy HK, Quon A. PMID: 19033789.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    64. 18F-FDG PET/CT evaluation of patients with ovarian carcinoma. Nucl Med Commun. 2008 Dec; 29(12):1046-51. Iagaru AH, Mittra ES, McDougall IR, Quon A, Gambhir SS. PMID: 18987524; PMCID: PMC2651960.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    65. (18)F-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan? Hell J Nucl Med. 2008 Sep-Dec; 11(3):153-6. Iagaru A, Wang Y, Mari C, Quon A, Goris ML, Horning S, Gambhir SS. PMID: 19081857.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    66. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2008 Nov 01; 72(3):678-86. Schellenberg D, Goodman KA, Lee F, Chang S, Kuo T, Ford JM, Fisher GA, Quon A, Desser TS, Norton J, Greco R, Yang GP, Koong AC. PMID: 18395362.
      View in: PubMed   Mentions: 129     Fields:    Translation:HumansCTClinical Trials
    67. 123I MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma. Mol Imaging Biol. 2008 Jan-Feb; 10(1):19-23. Iagaru A, Peterson D, Quon A, Dutta S, Twist C, Daghighian F, Gambhir SS, Albanese C. PMID: 17975716.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    68. FDG PET/CT detection of a gossypiboma in the neck. Clin Nucl Med. 2007 Nov; 32(11):893-5. Niederkohr RD, Hwang BJ, Quon A. PMID: 18075434.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    69. Molecular imaging techniques in body imaging. Radiology. 2007 Nov; 245(2):333-56. Margolis DJ, Hoffman JM, Herfkens RJ, Jeffrey RB, Quon A, Gambhir SS. PMID: 17940297.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    70. Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007 Oct 01; 69(2):328-33. Lee P, Weerasuriya DK, Lavori PW, Quon A, Hara W, Maxim PG, Le QT, Wakelee HA, Donington JS, Graves EE, Loo BW. PMID: 17869659.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    71. Clinical value of including the head and lower extremities in 18F-FDG PET/CT imaging for patients with malignant melanoma. Nucl Med Commun. 2007 Sep; 28(9):688-95. Niederkohr RD, Rosenberg J, Shabo G, Quon A. PMID: 17667747.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    72. Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease. J Clin Oncol. 2007 Sep 01; 25(25):3902-7. Advani R, Maeda L, Lavori P, Quon A, Hoppe R, Breslin S, Rosenberg SA, Horning SJ. PMID: 17664458.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    73. Advances in metabolic imaging for surgical oncology. Surg Oncol Clin N Am. 2007 Apr; 16(2):273-92. Iagaru A, Quon A. PMID: 17560512.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    74. Detection of bone metastases: assessment of integrated FDG PET/CT imaging. Radiology. 2007 Apr; 243(1):204-11. Taira AV, Herfkens RJ, Gambhir SS, Quon A. PMID: 17392254.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    75. No apparent alteration of F-18 FDG biodistribution when injected shortly after insulin glargine. Clin Nucl Med. 2007 Apr; 32(4):302-3. Niederkohr RD, Quon A. PMID: 17413580.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    76. Impact of integrated PET/CT on variability of target volume delineation in rectal cancer. Technol Cancer Res Treat. 2007 Feb; 6(1):31-6. Patel DA, Chang ST, Goodman KA, Quon A, Thorndyke B, Gambhir SS, McMillan A, Loo BW, Koong AC. PMID: 17241098.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    77. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. J Nucl Med. 2007 Jan; 48 Suppl 1:58S-67S. Quon A, Fischbein NJ, McDougall IR, Le QT, Loo BW, Pinto H, Kaplan MJ. PMID: 17204721.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    78. F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas. Clin Nucl Med. 2006 Dec; 31(12):754-60. Iagaru A, Quon A, McDougall IR, Gambhir SS. PMID: 17117068.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    79. F-18 fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp. Clin Nucl Med. 2006 Sep; 31(9):534-7. Vasanawala MS, Wang Y, Quon A, Gambhir SS. PMID: 16921276.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    80. "Flying through" and "flying around" a PET/CT scan: Pilot study and development of 3D integrated 18F-FDG PET/CT for virtual bronchoscopy and colonoscopy. J Nucl Med. 2006 Jul; 47(7):1081-7. Quon A, Napel S, Beaulieu CF, Gambhir SS. PMID: 16818940.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    81. Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography. Arch Dermatol. 2006 May; 142(5):577-84. Tsai EY, Taur A, Espinosa L, Quon A, Johnson D, Dick S, Chow S, Advani R, Warnke R, Kohler S, Hoppe RT, Kim YH. PMID: 16702495.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    82. Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients. Mol Imaging Biol. 2005 Sep-Oct; 7(5):369-76. Fueger BJ, Weber WA, Quon A, Crawford TL, Allen-Auerbach MS, Halpern BS, Ratib O, Phelps ME, Czernin J. PMID: 16220355.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    83. FDG-PET and beyond: molecular breast cancer imaging. J Clin Oncol. 2005 Mar 10; 23(8):1664-73. Quon A, Gambhir SS. PMID: 15755974.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    84. Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma. Mol Imaging Biol. 2004 Nov-Dec; 6(6):411-6. Allen-Auerbach M, Quon A, Weber WA, Obrzut S, Crawford T, Silverman DH, Ratib O, Phelps ME, Czernin J. PMID: 15564152.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    85. Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability. J Nucl Med. 2004 May; 45(5):797-801. Halpern BS, Dahlbom M, Quon A, Schiepers C, Waldherr C, Silverman DH, Ratib O, Czernin J. PMID: 15136629.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    86. Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's disease. Mol Imaging Biol. 2004 Jan-Feb; 6(1):47-54. Filmont JE, Yap CS, Ko F, Vranjesevic D, Quon A, Margolis DJ, Safaei A, Emmanouilides C, Silverman DH, Phelps ME, Czernin J. PMID: 15018828.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    87. Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation. Chest. 2003 Aug; 124(2):608-13. Filmont JE, Czernin J, Yap C, Silverman DH, Quon A, Phelps ME, Emmanouilides C. PMID: 12907550.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    88. Relationship between 18F-FDG uptake and breast density in women with normal breast tissue. J Nucl Med. 2003 Aug; 44(8):1238-42. Vranjesevic D, Schiepers C, Silverman DH, Quon A, Villalpando J, Dahlbom M, Phelps ME, Czernin J. PMID: 12902413.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    89. Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patients. Mol Imaging Biol. 2003 Jul-Aug; 5(4):232-9. Filmont JE, Vranjesevic D, Quon A, Margolis DJ, Ko F, Safaei A, Emmanouilides C, Silverman DH, Rao J, Valk PE, Phelps ME, Czernin J. PMID: 14499138.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    Andrew's Networks
    Concepts (294)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (36)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-8-gc1ed69da on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California